Technical Analysis for ATRA - Atara Biotherapeutics, Inc.

Grade Last Price % Change Price Change
grade F 23.99 -0.74% -0.18
ATRA closed down 0.74 percent on Friday, May 17, 2019, on 66 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ATRA trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -0.74%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.74%

Older signals for ATRA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of muscle wasting conditions and oncology. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. The company is also developing STM 434, a targeted therapy for ovarian cancer and other solid tumors; and a pipeline of product candidates that are in preclinical development. Atara Biotherapeutics, Inc. was founded in 2012 and is headquartered in Brisbane, California.
Medicine Biopharmaceutical Clinical Medicine Drugs Solid Tumors Ovarian Cancer End Stage Renal Disease Targeted Therapy
Is ATRA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 54.45
52 Week Low 23.58
Average Volume 613,467
200-Day Moving Average 36.9139
50-Day Moving Average 35.0112
20-Day Moving Average 30.7225
10-Day Moving Average 27.942
Average True Range 1.9349
ADX 29.13
+DI 11.5619
-DI 36.3823
Chandelier Exit (Long, 3 ATRs ) 30.7453
Chandelier Exit (Short, 3 ATRs ) 29.3847
Upper Bollinger Band 39.2996
Lower Bollinger Band 22.1454
Percent B (%b) 0.11
BandWidth 55.835951
MACD Line -3.1165
MACD Signal Line -2.3063
MACD Histogram -0.8103
Fundamentals Value
Market Cap 733.11 Million
Num Shares 30.6 Million
EPS -3.33
Price-to-Earnings (P/E) Ratio -7.20
Price-to-Sales 0.00
Price-to-Book 1.83
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.39
Resistance 3 (R3) 25.48 25.10 25.15
Resistance 2 (R2) 25.10 24.75 25.06 25.07
Resistance 1 (R1) 24.55 24.53 24.83 24.46 25.00
Pivot Point 24.17 24.17 24.31 24.13 24.17
Support 1 (S1) 23.62 23.82 23.90 23.53 22.98
Support 2 (S2) 23.24 23.60 23.20 22.91
Support 3 (S3) 22.69 23.24 22.83
Support 4 (S4) 22.60